Angion Biomedica Corp reports results for the quarter ended in June - Earnings Summary

Elicio Therapeutics

13/08/2021 01:37

* Angion Biomedica Corp  ANGN.OQ  reported a quarterly adjusted
loss of 58 cents​​ per share for the quarter ended in June. The
mean expectation of four analysts for the quarter was for a loss
of 69 cents per share.
* Revenue was $540.00 thousand​;  analysts expected $466.67
thousand. 
* Angion Biomedica Corp's reported EPS for the quarter was a
loss of 58 cents​.
* The mean earnings estimate of analysts had fallen by
about 11.3% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Angion Biomedica Corp shares had risen by 1.8% this quarter.
* The company reported a quarterly loss of $17.07 million.
* Wall Street's median 12-month price target for Angion
Biomedica Corp is $40.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 13 at 12:37 a.m.  ​All
figures in US dollars unless otherwise stated